Thomas Wegman

机构：Bristol-Myers Squibb (United States)

发表论文 21 篇 · 总被引 382 次 · h-index 4

代表论文

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II , Randomized, Double‐Blind , Placebo‐Controlled Trial (2022 · Arthritis & Rheumatology · 被引 268)
Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2–IIB cervical cancer patients (2013 · Annals of Oncology · 被引 83)
A Phase I Clinical Trial to Assess Safety and Tolerability of Injectable Collagenase in Women with Symptomatic Uterine Fibroids (2021 · Reproductive Sciences · 被引 18)
ECRC heads search for composites recycling solutions (2007 · Reinforced Plastics · 被引 6)
Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus (2024 · Expert Opinion on Investigational Drugs · 被引 3)
POS0543 KINETICS OF MUCOCUTANEOUS AND MUSCULOSKELETAL RESPONSES TO DEUCRAVACITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN THE PHASE 2 PAISLEY TRIAL (2024 · Annals of the Rheumatic Diseases · 被引 1)